World Health Organization approves first mpox diagnostic test for emergency use
The first mpox diagnostic test has been cleared through the World Health Organization’s Emergency Use Listing, opening a faster procurement route for the countries hit hardest by the outbreak. Abbott’s Alinity m MPXV assay detects both clades of the virus from rash samples, and UN agencies can now order it directly for places where national approval pathways would otherwise take months. That speed matters: in 2024, only 37% of suspected mpox cases in the Democratic Republic of the Congo were confirmed by testing, leaving outbreaks harder to trace. Three more tests are already under WHO review, with more manufacturers in talks. It’s a hopeful signal that the world is learning from past pandemics — building diverse, quality-assured tools before bottlenecks become catastrophes.









